乳酸—磷酸酯共聚物为载体的高分子药物的合成及其控释研究

以５－氟尿嘧啶为药物模型，以乳酸－磷酸酯共聚物为高分子药物载体，合成了侧链带药的乳酸－磷酸酯共聚物药物。用＾ＨＮＭＲ，ＩＲ，ＵＶ谱对其结果进行了表征。测定高分子药物中５－ＦＵ的含量，研究了高分子药物的体外释药物能及共聚物组成对释药性能的影响。     

二(顺丁烯二酸异丙酯酰氧基)-异丙氧基钕及其与甲基丙烯酸甲酯共聚物的研究

用三异丙氧基钕与顺丁烯二酸酐反应合成含钕单体二（顺丁烯二酸异丙酯酰氧基） 异丙氧基钕，并与甲基丙烯酸甲酯（ＭＭＡ）共聚而制得含钕共聚物．用元素分析、ＩＲ、ＸＰＳ和ＳＥＭ对其结构进行表征，并研究了其热性能、光学性能和磁性．表明含钕共聚物是一种具有优异热稳定性、高透光率和大折光率，以及具有光选择吸收性和顺磁性的高分子材料     

乳酸-磷酸酯共聚物为载体的高分子药物的合成及其控释研究

以5-氟尿嘧啶(5-FU)为药物模型,以乳酸-磷酸酯共聚物为高分子药物载体,合成了侧链带药的乳酸-磷酸酯共聚物药物。用¹HNMR、IR、UV谱对其结构进行了表征。测定高分子药物中5-FU的含量,研究了高分子药物的体外释药性能及共聚物组成对释药性能的影响。     

茂金属催化乙烯与降冰片烯共聚合研究

研究了茂金属催化体系Ｍｅ２ＳｉＣｐ２ＭＣｌ２／ＭＡＯ（Ｍ＝Ｚｒ，ｔｉ）催化乙烯与降冰片烯共聚合，考察了不同聚合条件下的共聚及乙烯动力学行为，对共聚物的结构进行了ＤＳＣ，１３Ｃ ＮＭＲ表征．研究表明，在相同的聚合条件下，Ｚｒ较Ｔｉ有更佳的共聚合催化性能．在相近的投料比条件下，得到了降冰片烯含量和Ｔｇ均较文献高的乙烯与降冰片烯的共聚物．     

新型脂肪族酯和磷酸酯共聚物的合成与表征

为了优化脂肪族聚酯和聚磷酸酯在药物控释及基因治疗领域的性能, 以己二酰氯、二氯磷酸乙酯和二缩三乙二醇为原料, 用共缩聚的方法合成了一类新型脂肪族酯和磷酸酯的共聚物. 运用1H NMR, IR对共聚物的结构进行了表征; 利用MALDI-TOF MS测定了共聚物的分子量; 研究了反应时间、投料顺序、溶剂、反应温度和缚酸剂对聚合反应的影响; 通过动态接触角的测定, 探讨了此类聚合物的亲疏水性能; 以中性红为模型药物, 研究了该类聚合物的药物缓释性能.     

聚环氧乙烷为支链的两亲共聚物的表征及性能

用端基带有甲基丙烯酸酯的聚环氧乙烷大分子单体（ＰＥＯ—ＭＡ）分别与小分子单体苯乙烯（Ｓ）、甲基丙烯酸甲酯（ＭＭＡ）、丙烯酸甲酯（ＭＡ）溶液自由基共聚合得到了三种具有不同主链结构的以聚环氧乙烷（ＰＥＯ）为支链的两亲接枝嵌段共聚物（分别简写为：ＰＳ─ｇ─ＰＥＯ，ＰＭＭＡ─ｇ─ＰＥＯ，ＰＭＡ─ｇ─ＰＥＯ）．用ＧＰＣ、ＩＲ、１Ｈ─ＮＭＲ、ＷＡＸＤ和ＤＳＣ对其结构进行了表征．研究了接校共聚物的结晶性能、乳化性能以及在Ｗｉｌｌｉａｍｓｏｎ反应中相转移催化作用．结果表明，不同主链结构有不同的结晶度，并随支链ＰＥＯ含量的增加，分子量的增大而提高；其乳化体积和相转移催化反应的转化率均随着共聚物浓度的增加、支链ＰＥＯ含量的增人而增大，随支链ＰＥＯ分子量的提高而减小．     

马来酸酐─环氧丙烷共聚物的合成及结构表征

本文将稀土络合物Ｎｄ（Ｐ２０４）３、Ｎｄ（Ｐ５０７）３、Ｎｄ（ｎａＰｈ）３、Ｎｄ（ａｃａｃ）３．３Ｈ２Ｏ与烷基铝组成的二元体系催化剂用于共聚马来酸酐（ＭＡｎ）与环氧丙烷（ＰＯ）获得成功．并采用１Ｈ—ＮＭＲ研究了共聚物三元组序列分布．结果表明，稀土络合催化剂为ＭＡｎ与ＰＯ共聚的优良催化刑，可得到高转化率、高交替度共聚物．共聚物数均分子量Ｍｎ和分子量分布分别为２０００—３０００、１．３—１．７，共聚物中ＭＡｎ的摩尔含量４０％以上．共聚物组成及序列分布与投料比、催化剂种类、溶剂性质等有关．理论计算表明，序列分布符合三级马尔可夫（Ｍａｒｋｏｆｆｉａｎ）过程．     

含氢聚甲基硅氧烷/丙烯酸丁酯/羟甲基丙烯酰胺复合乳液的研究——原料配比对乳液及胶膜性能的影响

采用含氢聚甲基硅氧烷（ＰＨＭＳ）与丙烯酸酯类单体进行接枝共聚，制得兼具二者优异性能的新型ＰＨＭＳ／丙烯酸丁酯（ＢＡ）／羟甲基丙烯酰胺（ＮＭＡ）复合聚合物乳液．讨论了ＰＨＭＳ、ＮＭＡ和引发剂用量对该复合乳液的聚合反应转化率、稳定性及粘度的影响．采用透射电子显微镜和粒度测试仪对不同反应条件下制备的乳液的粒度进行了测定．同时对聚合反应的机理、产物的结构及胶膜性能作了考察．结果表明：通过乳液聚合，得到了ＰＨＭＳ／ＢＡ／ＮＭＡ共聚物，控制ＰＨＭＳ、ＮＭＡ、引发剂等用量可制得粒度和粘度适中，具有较高转化率的稳定ＰＨＭＳ／ＢＡ／ＮＭＡ复合聚合物乳液，该乳液所制得的胶膜具有优良的性能     

聚乙二醇改性聚乳酸的研究

将丙交酯（ＤＬ ＬＡ）与聚乙二醇（ＰＥＧ）共聚得到了一系列高分子量的共聚物．用ＩＲ、１Ｈ ＮＭＲ和ＤＭＡ对它的结构和粘弹性进行了表征，并测定了其力学性能，同时对材料在加工过程中特征粘度的变化也进行了研究．结果表明，ＰＥＧ与ＬＡ的共聚物是一种三嵌段结构ＨＯ ＰＬＡ ＰＥＧ ＰＬＡ ＯＨ．当ＰＥＧ含量增加时，强度下降，伸长率增加，共聚物逐渐由脆性向韧性转变，因此用ＰＥＧ改性的ＰＬＡ是一种综合性能可调控的生物降解材料     

含环氧基的丙烯酸酯弹性体的合成及其对聚氯乙烯改性研究

以丙烯酸丁酯（ＢＡ），甲基丙烯酸甲酯（ＭＭＡ）和甲基丙烯酸缩水甘油酯（ＧＭＡ）为原料，通过分段乳液聚合，合成了一系列具有不同组成结构的三元共聚物—Ｐ（Ｂ—Ｍ—Ｇ）弹性体，并对此弹性体改性的ＰＶＣ的抗冲击性能进行了系统研究．结果表明：改性剂组成结构的变化对改性体系的冲击性能有较大影响，改性ＰＶＣ的冲击性能最高可达７９ｋＪ／ｍ２．动态力学及ＳＥＭ实验表明，ＰＶＣ与改性体系系部分相容的共混体系，其断裂行为是明显的韧性断裂特征．本文还对改性体系的力学性能进行了研究．     

磷酸酯-碳酸酯共聚物的合成及其微球释药性能研究

在光气、二氯磷酸溴乙酯和双酚A反应后,用三甲胺季铵化侧链,得到了4种两亲性磷酸酯-碳酸酯共聚物.用IR、¹HNMR及元素分析表征了共聚物,测量了水接触角和Mn,研究了其在pH为7.4磷酸盐缓冲溶液中的降解性能.制得了共聚物微球,并研究了微球的形态、粒径及其对抗肿瘤药物5-Fu的释放性能.     

聚磷酸酯—聚氨酯药物释放材料的合成

报道了一类新型生物可降解和生物相容性药物释放材料聚磷酸酯－聚氨酯的合成和表征，研究了这类聚合物的体外降解及其对牛血清白蛋白的释放性能。     

Stereocomplexes of Triblock Poly(lactide- PEG2000-lactide) as Carrier of Drugs

Triblock copolymers of poly(lactide)-poly(ethylene-glycol)-poly(lactide) (PLA-PEG₂₀₀₀-PLA) were synthesized by ring-opening polymerization of lactide and PEG₂₀₀₀ diol as co-catalyst. Stereocomplexes with particle sizes ranging from nanometers to microns were obtained by mixing acetonitrile solutions of pairs of enantiomeric homopoly(lactide) and the triblock copolymers. The stereocomplexes exhibited higher crystalline melting temperatures than the optically pure polymers. The ratio of PLA terminals in the copolymers had a significant effect on their stereocomplex degradation and drug release. These stereocomplexes were used for the encapsulation of dexamethasone for controlled release applications. Dexamethasone phosphate loading capacity, in vitro release, degradation and stability of polymers and formulation were investigated for one month. An increase in the dexamethsone phosphate content in the stereocomplex or a decrease in the PLA ratio in the copolymer resulted in a faster release of drug and polymer degradation.     

Synthesis and Properties of Biodegradable Copolymers of 9-Phenyl-2, 4, 8, 10-tetraoxaspiro-[5, 5]undcane-3-one and Ethylene Ethyl Phosphate

Novel biodegradable copolymer poly（CC-co-EEP） was synthesized by ring-opening copolymerization of cyclic carbonate 9-phenyl-2, 4, 8, 10-tetraoxaspiro-[5, 5]undcane-3-one （CC） and ethylene ethyl phosphate （EEP）. The obtained poly （CC-co-EEP）s were characterized by FTIR, ^1H NMR, ^13C NMR and gel permeation chromatography （GPC）. In vitro hydrolytic degradation of the copolymers were investigated in phosphate buffer solution （pH=7.4）. Hydrophilic phosphate units apparently improved the degradability of poly（carbonate-phosphate）.     

Stereoselective synthesis of PSI-352938: a β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyl-3',5'-cyclic phosphate nucleotide prodrug for the treatment of HCV

PSI-352938 is a novel 2'-deoxy-2'-α-fluoro-2'-β-C-methyl 3',5'-cyclic phosphate nucleotide prodrug currently under investigation for the treatment of hepatitis C virus (HCV) infection. PSI-352938 demonstrated superior characteristics in vitro that include broad genotype coverage, superior resistance profile, and high levels of active triphosphate in vivo in the liver compared to our first and second generation nucleoside inhibitors of this class. Consequently, PSI-352938 was selected for further development and an efficient and scalable synthesis was sought to support clinical development. We report an improved, diastereoselective synthesis of a key 1'-β-nucleoside intermediate 13 via S(N)2 displacement of 1-α-bromo ribofuranose sugar 16 with the potassium salt of 6-chloro-2-amino purine and an efficient method to prepare cis-Rp cyclic phosphate (PSI-352938) in a highly stereoselective manner without any chromatographic purification. The 1-α-bromo sugar 16 was stereospecifically prepared from the corresponding 1-β-lactol in high yield under mild bromination conditions using CBr(4)/PPh(3) (Appel reaction). The desired cis-Rp 3',5'-cyclic phosphate construction was accomplished using isopropyl phosphorodichloridate readily obtained from POCl(3) and isopropyl alcohol. The base combination of Et(3)N/NMI was identified as a key factor for producing PSI-352938 as the major (>95%) diastereomer (cis-Rp) in high yield after the final cyclization step. The current route described in this article was successfully used to produce PSI-352938 on multikilogram scale.     

Esters phosphoriques cycliques ou non cycliques de quelques O-isopropylidène-1,2-α-D-pentofurannoses. Communication préliminaire

Cyclic and acyclic phosphate esters of some 1,2-O-isopropylidene-α-D -pentofuranoses When treated with monophenyl phosphorodichloridate, 1,2-O-isopropylidene-α-D -xylofuranose gave the two possible, isolable isomers of the corresponding 3,5-cylic phenylphosphate. Upon phosphorylation of the same sugar derivative using bis (2,2,2-trichloroethyl) phosphorochloridate only one isomer was formed. The same situation obtained when preparing 1,2-O-isopropylidene-α-D -ribofuranose-3,5-cyclic phenylphosphate. The synthesis of a new kind of sugar phosphate with a branched-chain unsaturated sugar moiety namely the trans-3-deoxy-3-C-cyanomethylene-1,2-O-isopropylidene-D -erytho-pentofuranose 5-bis(2,2,2-trichloroethyl) phosphate is also described.     

侧基带有L-苯丙氨酸的手性两亲嵌段共聚物的合成及其自组装行为

N3-苯丙氨酸与嵌段共聚物聚乙二醇-b-聚炔丙基缩水甘油(MPEO-b-PGPE)发生"click"反应,合成了具有光学活性的两亲嵌段共聚物聚乙二醇-B-聚L-苯丙氨酸三唑基缩水甘油(MPEO-b-PGTP),用1H-NMR和元素分析对其结构和组成进行表征.并对其自组装行为进行研究,滴体积法测定MPEO-b-PGTP溶...     

The Preparation and Biodegradable Properties of Poly(L‐lactic acid)‐Poly(ϵ‐caprolactone) Multiblock Copolymers

Multi‐block copolymers of PLLA and PCL were prepared by a coupling reaction between PLLA and PCL prepolymers with –NCO end groups. FTIR proved that the products were PLLA‐PCL copolymers. The weight‐average molecular weight of the copolymers was up to 180,000 at a composition of 60% PLLA and 40% PCL. The degradation properties of PLLA and PLLA‐PCL copolymers were studied by a soil burial test and a hydrolysis test in a phosphate‐buffer solution. The degradation rate was estimated by the mass loss, molecular weight reduction, pH value changes and swelling index; the degradation rates of the copolymers were a function of the composition of PLLA and PCL. Increasing PCL content in the copolymers resulted in lower degradation rate.     

阻垢剂的性能及其协同效应

阻垢剂的性能及其协同效应路长青，韩应琳，马迎军，赵任辉，刁月民（南京化工大学应用化学系南京２１０００９）关键词有机膦酸，共聚物，阻垢剂，协同效应有机膦酸和某些共聚物是目前使用最广泛的两类冷却水阻垢剂。有机膦酸对许多金属离子，如钙、镁、铁和锌等具有优异...